NAFTZGER J. CHRISTOPHER (General Counsel and CCO) sold 11.6% of their position (11.33K shares) of ARBUTUS BIOPHARMA CORP on the open market
Open‑market sale worth $37.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0001447028-25-000037
Officer· General Counsel and CCO
Since Jul 2023
-11.33K
Net shares
Net seller
$37.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.33K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−11.33K
Price / share
$3.28
Trade value
$37.21K
% of position
11.6%
2/4/2025
97.58K→86.24K
Total
Net shares
−11.33K
Net value
-$37.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/4/2025 | S · Sale | −11.33K | $3.28 | $37.21K | 11.6% | 97.58K | 86.24K |
| Total | −11.33K | -$37.21K | ||||||
Derivative Transactions0
No derivative transactions reported